BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 38572444)

  • 1. Iron toxicity and chelation therapy.
    Britton RS; Leicester KL; Bacon BR
    Int J Hematol; 2002 Oct; 76(3):219-28. PubMed ID: 12416732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thalassemia.
    Cohen AR; Galanello R; Pennell DJ; Cunningham MJ; Vichinsky E
    Hematology Am Soc Hematol Educ Program; 2004; ():14-34. PubMed ID: 15561674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deferiprone-resveratrol hybrid attenuates iron accumulation, oxidative stress, and antioxidant defenses in iron-loaded human Huh7 hepatic cells.
    Li J; Koonyosying P; Korsieporn W; Paradee N; Hutachok N; Xu H; Ma Y; Chuljerm H; Srichairatanakool S
    Front Mol Biosci; 2024; 11():1364261. PubMed ID: 38572444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying a Deferiprone-Resveratrol Hybrid as an Effective Lipophilic Anti-Plasmodial Agent.
    Maneekesorn S; Chuljerm H; Koonyosying P; Uthaipibull C; Ma Y; Srichairatanakool S
    Molecules; 2021 Jul; 26(13):. PubMed ID: 34279413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Green tea extract modulates oxidative tissue injury in beta-thalassemic mice by chelation of redox iron and inhibition of lipid peroxidation.
    Koonyosying P; Kongkarnka S; Uthaipibull C; Svasti S; Fucharoen S; Srichairatanakool S
    Biomed Pharmacother; 2018 Dec; 108():1694-1702. PubMed ID: 30372872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The oral iron chelator deferiprone protects against systemic iron overload-induced retinal degeneration in hepcidin knockout mice.
    Song D; Zhao L; Li Y; Hadziahmetovic M; Song Y; Connelly J; Spino M; Dunaief JL
    Invest Ophthalmol Vis Sci; 2014 Jun; 55(7):4525-32. PubMed ID: 24970260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron Chelation Property, Antioxidant Activity, and Hepatoprotective Effect of 6-Gingerol-Rich Ginger (
    Chuljerm H; Paradee N; Katekaew D; Nantachai P; Settakorn K; Srichairatanakool S; Koonyosying P
    Plants (Basel); 2023 Aug; 12(16):. PubMed ID: 37631148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonistic antimalarial properties of a methoxyamino chalcone derivative and 3-hydroxypyridinones in combination with dihydroartemisinin against
    Kampoun T; Koonyosying P; Ruangsuriya J; Prommana P; Shaw PJ; Kamchonwongpaisan S; Suwito H; Puspaningsih NNT; Uthaipibull C; Srichairatanakool S
    PeerJ; 2023; 11():e15187. PubMed ID: 37131988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of green tea extract treatment on erythropoiesis and iron parameters in iron-overloaded β-thalassemic mice.
    Settakorn K; Kongkarnka S; Chompupoung A; Svasti S; Fucharoen S; Porter JB; Srichairatanakool S; Koonyosying P
    Front Physiol; 2022; 13():1053060. PubMed ID: 36620219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Mitochondrial Iron Overload in Mediating Cell Death in H9c2 Cells.
    Tam E; Sung HK; Lam NH; You S; Cho S; Ahmed SM; Abdul-Sater AA; Sweeney G
    Cells; 2022 Dec; 12(1):. PubMed ID: 36611912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deferiprone-Resveratrol Hybrid, an Iron-Chelating Compound, Acts as an Antimalarial and Hepatoprotective Agent in
    Chuljerm H; Maneekesorn S; Punsawad C; Somsak V; Ma Y; Ruangsuriya J; Srichairatanakool S; Koonyosying P
    Bioinorg Chem Appl; 2022; 2022():3869337. PubMed ID: 36466999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol ameliorates iron overload induced liver fibrosis in mice by regulating iron homeostasis.
    Wang H; Jiang C; Yang Y; Li J; Wang Y; Wang C; Gao Y
    PeerJ; 2022; 10():e13592. PubMed ID: 35698613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Malarial and Anti-Lipid Peroxidation Activities of Deferiprone-Resveratrol Hybrid in
    Chuljerm H; Maneekesorn S; Somsak V; Ma Y; Srichairatanakool S; Koonyosying P
    Biology (Basel); 2021 Sep; 10(9):. PubMed ID: 34571788
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.